Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Pancreatic Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Kidney Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Uterine Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Colon Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Sarcoma

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Penile Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Liver Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Vaginal Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Bone Mets

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Kaposi's Sarcoma

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Vulvar Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Testicular Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Brain Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
517.00 mi. away
P: (281) 277-5200

More Details View Practice Page

Pages